HW
PAHC icon

Hancock Whitney’s Phibro Animal Health PAHC Stock Holding History

Hancock Whitney’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-9,100
Closed -$390K – 846
2018
Q3 		$390K Hold
9,100
– – 0.01% 693
2018
Q2 		$419K Buy
+9,100
New +$403K 0.02% 446

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Hancock Whitney's PAHC Position: Q4 2018 in Review

Hancock Whitney sold out of Phibro Animal Health (PAHC) in Q4 2018, closing a stake of 9,100 shares — an estimated $390K sold.

Hancock Whitney first reported a position in PAHC in Q2 2018 and held it in 2 quarters. The position peaked at $419K in Q2 2018. 191 funds tracked by Wall St. Rank hold PAHC as of Q4 2018.

  • Hancock Whitney reported no remaining Phibro Animal Health position as of Q4 2018 after selling out during the quarter.
  • Hancock Whitney sold 9,100 Phibro Animal Health shares in Q4 2018, an estimated $390K.
  • Hancock Whitney first reported a position in Phibro Animal Health in Q2 2018 and held it in 2 quarters.
  • Hancock Whitney's Phibro Animal Health position peaked at $419K in Q2 2018.
  • 191 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2018.

Based on Hancock Whitney's 13F filing for Q4 2018, filed 15 Feb 2019.